BOULDER, Colo., Nov. 3, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, ...
Show More All authors: Washington University School of Medicine, St Louis, MO. A currently 74-year-old white woman with hypertension, hypothyroidism, and diabetes mellitus type 2 presented initially ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback